Search results
Merck and other pharma giants are bracing for competition to their blockbuster drugs. Here's how.
Quartz· 4 hours agoEvery pharmaceutical company is constantly searching for its next blockbuster — the billion-dollar...
Dow Jones Futures Fall As Uber Dives On Surprise Loss; Tesla Slides On Autopilot Probe
Investor's Business Daily· 17 minutes agoChipotle Mexican Grill, NXP Semiconductor, Texas Roadhouse and Tradeweb Markets — plus Dow Jones...
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via Yahoo Finance· 6 days agoAfter topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co...
...Singapore and Southeast Asia Through Partnerships with EnterpriseSG and Merck, Alongside...
The Pendulum· 11 hours agoSince 2019, NSG BioLabs has been a leader in co-working lab spaces in Singapore, and has nurtured over 40 biotech companies, of which the startups have achieved nearly US$400 million
Dow Jones Drug Giant Merck, Nvidia Eye Buy Points In Current Stock Market
Investor's Business Daily· 2 days agoAmong the best stocks to watch, Dow Jones drug giant Merck, Nvidia, Chipotle Mexican Grill and NXP...
UK’s leading lab supplier launches investigation into N-word slurs on products
The Independent via Yahoo News· 4 hours agoThe products in question were created on its system in 2009 and 2023 and were provided in data files...
Merck First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 2 days agoMerck (NYSE:MRK) First Quarter 2024 Results Key Financial Results Revenue: US$15.8b (up 8.9% from 1Q...
Cerevance receives milestone payment under Alzheimer's collaboration with Merck
Seeking Alpha· 6 days agoPrivately held Cerevance receives milestone payment from Merck for Alzheimer's research...
Merck's KEYTRUDA shows survival benefit in gastric cancer trial By Investing.com
Investing.com· 7 days agoMerck & Co., Inc., a leading pharmaceutical company, announced positive results from the Phase 3...
Gossamer sells rights to drug it hopes can rival a new Merck therapy
BioPharma Dive via Yahoo Finance· 2 days agoOne analyst thinks the collaboration “bodes well” for Gossamer, which has had trouble convincing...